Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000691390 | SCV000819166 | uncertain significance | Maple syrup urine disease | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with valine at codon 406 of the DBT protein (p.Gly406Val). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and valine. This variant is present in population databases (rs767154711, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with DBT-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330901 | SCV004037631 | uncertain significance | not specified | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000691390 | SCV004050144 | uncertain significance | Maple syrup urine disease | 2023-04-11 | criteria provided, single submitter | clinical testing |